Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Background check: Profound differences in serum antibody isotypes discourage C57BL/6 substrain interchange in immunology experiments.

Jones BG, Penkert RR, Surman SL, Sealy RE, Pelletier S, Berns H, Hurwitz JL.

Immunol Lett. 2019 Aug 19. pii: S0165-2478(19)30261-5. doi: 10.1016/j.imlet.2019.05.011. [Epub ahead of print]

PMID:
31437463
2.

The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.

Lingemann M, McCarty T, Liu X, Buchholz UJ, Surman S, Martin SE, Collins PL, Munir S.

PLoS Pathog. 2019 Aug 5;15(8):e1007963. doi: 10.1371/journal.ppat.1007963. eCollection 2019 Aug.

3.

Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.

Penkert RR, Rowe HM, Surman SL, Sealy RE, Rosch J, Hurwitz JL.

Front Immunol. 2019 Jul 17;10:1576. doi: 10.3389/fimmu.2019.01576. eCollection 2019.

4.

Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Sealy RE, Jones BG, Surman SL, Penkert RR, Pelletier S, Neale G, Hurwitz JL.

Vaccines (Basel). 2019 Feb 27;7(1). pii: E26. doi: 10.3390/vaccines7010026. Review.

5.

Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.

Liang B, Kabatova B, Kabat J, Dorward DW, Liu X, Surman S, Liu X, Moseman AP, Buchholz UJ, Collins PL, Munir S.

J Virol. 2019 Mar 21;93(7). pii: e02043-18. doi: 10.1128/JVI.02043-18. Print 2019 Apr 1.

PMID:
30651356
6.

Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Jones BG, Sealy RE, Penkert RR, Surman SL, Maul RW, Neale G, Xu B, Gearhart PJ, Hurwitz JL.

Int Immunol. 2019 Mar 5;31(3):141-156. doi: 10.1093/intimm/dxy074.

PMID:
30407507
7.

Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

Surman SL, Jones BG, Woodland DL, Hurwitz JL.

Viral Immunol. 2017 Dec;30(10):737-743. doi: 10.1089/vim.2017.0086. Epub 2017 Nov 13.

8.

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.

Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S.

J Virol. 2017 Oct 27;91(22). pii: e01101-17. doi: 10.1128/JVI.01101-17. Print 2017 Nov 15.

9.

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL.

Virology. 2017 Sep;509:60-66. doi: 10.1016/j.virol.2017.05.021. Epub 2017 Jun 9.

10.

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Penkert RR, Young NS, Surman SL, Sealy RE, Rosch J, Dormitzer PR, Settembre EC, Chandramouli S, Wong S, Hankins JS, Hurwitz JL.

Vaccine. 2017 Jun 22;35(29):3615-3620. doi: 10.1016/j.vaccine.2017.05.022. Epub 2017 May 26.

11.

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S.

J Virol. 2017 Jul 12;91(15). pii: e00189-17. doi: 10.1128/JVI.00189-17. Print 2017 Aug 1.

12.

CD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.

Sealy RE, Surman SL, Hurwitz JL.

Vaccine. 2017 May 9;35(20):2617-2621. doi: 10.1016/j.vaccine.2017.03.073. Epub 2017 Apr 11.

13.

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus.

Samarasinghe AE, Melo RC, Duan S, LeMessurier KS, Liedmann S, Surman SL, Lee JJ, Hurwitz JL, Thomas PG, McCullers JA.

J Immunol. 2017 Apr 15;198(8):3214-3226. doi: 10.4049/jimmunol.1600787. Epub 2017 Mar 10.

14.

Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.

Lingemann M, Liu X, Surman S, Liang B, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S.

J Virol. 2017 Apr 28;91(10). pii: e02469-16. doi: 10.1128/JVI.02469-16. Print 2017 May 15.

15.

Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners.

Sealy RE, Surman SL, Vogel P, Hurwitz JL.

Int Immunol. 2016 Nov;28(11):559-564. Epub 2016 Jul 18.

16.

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

Liang B, Ngwuta JO, Herbert R, Swerczek J, Dorward DW, Amaro-Carambot E, Mackow N, Kabatova B, Lingemann M, Surman S, Yang L, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Schaap-Nutt A, Collins PL, Munir S.

J Virol. 2016 Oct 14;90(21):10022-10038. doi: 10.1128/JVI.01196-16. Print 2016 Nov 1.

17.

An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens.

Meliopoulos VA, Van de Velde LA, Van de Velde NC, Karlsson EA, Neale G, Vogel P, Guy C, Sharma S, Duan S, Surman SL, Jones BG, Johnson MD, Bosio C, Jolly L, Jenkins RG, Hurwitz JL, Rosch JW, Sheppard D, Thomas PG, Murray PJ, Schultz-Cherry S.

PLoS Pathog. 2016 Aug 9;12(8):e1005804. doi: 10.1371/journal.ppat.1005804. eCollection 2016 Aug.

18.

Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Surman SL, Penkert RR, Jones BG, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2016 Jan 6;23(3):219-27. doi: 10.1128/CVI.00739-15.

19.

Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.

Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL.

Viral Immunol. 2016 Jan-Feb;29(1):64-70. doi: 10.1089/vim.2015.0078. Epub 2015 Nov 6.

20.

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells.

Penkert RR, Surman SL, Jones BG, Sealy RE, Vogel P, Neale G, Hurwitz JL.

Int Immunol. 2016 Mar;28(3):139-52. doi: 10.1093/intimm/dxv064. Epub 2015 Oct 27.

21.

Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.

Mackow N, Amaro-Carambot E, Liang B, Surman S, Lingemann M, Yang L, Collins PL, Munir S.

J Virol. 2015 Oct;89(20):10319-32. doi: 10.1128/JVI.01380-15. Epub 2015 Jul 29.

22.

Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.

Liang B, Surman S, Amaro-Carambot E, Kabatova B, Mackow N, Lingemann M, Yang L, McLellan JS, Graham BS, Kwong PD, Schaap-Nutt A, Collins PL, Munir S.

J Virol. 2015 Sep;89(18):9499-510. doi: 10.1128/JVI.01373-15. Epub 2015 Jul 8.

23.

The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.

Lingemann M, Surman S, Amaro-Carambot E, Schaap-Nutt A, Collins PL, Munir S.

J Virol. 2015 Mar;89(6):3318-31. doi: 10.1128/JVI.03148-14. Epub 2015 Jan 14.

24.

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.

Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, Allison K, Howlett N, Utech J, Allay J, Knight J, Sleep S, Meagher MM, Russell CJ, Portner A, Hurwitz JL.

Clin Vaccine Immunol. 2015 Mar;22(3):298-303. doi: 10.1128/CVI.00618-14. Epub 2014 Dec 31.

25.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL.

Int Immunol. 2015 May;27(5):229-36. doi: 10.1093/intimm/dxu107. Epub 2014 Dec 4.

26.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL.

Vaccine. 2014 May 30;32(26):3264-73. doi: 10.1016/j.vaccine.2014.03.088. Epub 2014 Apr 14.

27.

Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL.

Vaccine. 2014 May 7;32(22):2521-4. doi: 10.1016/j.vaccine.2014.03.025. Epub 2014 Mar 21.

28.

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2014 Apr;21(4):598-601. doi: 10.1128/CVI.00757-13. Epub 2014 Feb 19.

29.

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.

Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.

J Virol. 2014 Apr;88(8):4237-50. doi: 10.1128/JVI.03481-13. Epub 2014 Jan 29.

30.

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL.

PLoS One. 2014 Jan 22;9(1):e86554. doi: 10.1371/journal.pone.0086554. eCollection 2014.

31.

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Rudraraju R, Sealy RE, Surman SL, Thomas PG, Dayton BH, Hurwitz JL.

Viral Immunol. 2013 Dec;26(6):378-84. doi: 10.1089/vim.2013.0033.

32.

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model.

Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, McClaren JL, Tam VC, Dash P, Noonan JG, Jones BG, Surman SL, Peschon JJ, Diercks AH, Hurwitz JL, Doherty PC, Thomas PG, Aderem A.

J Gen Virol. 2014 Feb;95(Pt 2):350-62. doi: 10.1099/vir.0.058438-0. Epub 2013 Nov 16.

33.

The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

Keating R, Hertz T, Wehenkel M, Harris TL, Edwards BA, McClaren JL, Brown SA, Surman S, Wilson ZS, Bradley P, Hurwitz J, Chi H, Doherty PC, Thomas PG, McGargill MA.

Nat Immunol. 2013 Dec;14(12):1266-76. doi: 10.1038/ni.2741. Epub 2013 Oct 20.

34.

Continuous glucose monitoring in small animals.

Surman S, Fleeman L.

Vet Clin North Am Small Anim Pract. 2013 Mar;43(2):381-406. doi: 10.1016/j.cvsm.2013.01.002. Review.

PMID:
23522178
35.

Respiratory syncytial virus: current progress in vaccine development.

Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL.

Viruses. 2013 Feb 5;5(2):577-94. doi: 10.3390/v5020577. Review.

36.

Arterial blood pressure, proteinuria, and renal histopathology in clinically healthy retired racing greyhounds.

Surman S, Couto CG, Dibartola SP, Chew DJ.

J Vet Intern Med. 2012 Nov-Dec;26(6):1320-9. doi: 10.1111/j.1939-1676.2012.01008.x. Epub 2012 Oct 20.

37.

Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.

Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL.

Viral Immunol. 2012 Aug;25(4):341-4. doi: 10.1089/vim.2012.0023. Epub 2012 Jul 19.

38.

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.

Jones BG, Sealy RE, Zhan X, Freiden PJ, Surman SL, Blanchard JL, Hurwitz JL.

Vaccine. 2012 May 2;30(21):3188-95. doi: 10.1016/j.vaccine.2012.03.001. Epub 2012 Mar 14.

39.

Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Rudraraju R, Surman SL, Jones BG, Sealy R, Woodland DL, Hurwitz JL.

Clin Vaccine Immunol. 2012 May;19(5):757-65. doi: 10.1128/CVI.05576-11. Epub 2012 Mar 7.

40.

The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome.

Schomacker H, Hebner RM, Boonyaratanakornkit J, Surman S, Amaro-Carambot E, Collins PL, Schmidt AC.

PLoS One. 2012;7(2):e28382. doi: 10.1371/journal.pone.0028382. Epub 2012 Feb 15.

41.

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.

Karron RA, Thumar B, Schappell E, Surman S, Murphy BR, Collins PL, Schmidt AC.

Vaccine. 2012 Jun 6;30(26):3975-81. doi: 10.1016/j.vaccine.2011.12.022. Epub 2011 Dec 14.

42.

The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children.

Karron RA, Casey R, Thumar B, Surman S, Murphy BR, Collins PL, Schmidt AC.

Pediatr Infect Dis J. 2011 Oct;30(10):e186-91. doi: 10.1097/INF.0b013e31822ea24f.

43.

Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, Russell CJ.

PLoS Pathog. 2011 Jul;7(7):e1002134. doi: 10.1371/journal.ppat.1002134. Epub 2011 Jul 7.

44.

Clonally related CD8+ T cells responsible for rapid population of both diffuse nasal-associated lymphoid tissue and lung after respiratory virus infection.

Surman SL, Rudraraju R, Woodland DL, Dash P, Thomas PG, Hurwitz JL.

J Immunol. 2011 Jul 15;187(2):835-41. doi: 10.4049/jimmunol.1100125. Epub 2011 Jun 20.

45.

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.

Rudraraju R, Surman S, Jones B, Sealy R, Woodland DL, Hurwitz JL.

Virology. 2011 Feb 20;410(2):429-436. doi: 10.1016/j.virol.2010.12.017. Epub 2011 Jan 11.

46.

The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R.

Boonyaratanakornkit J, Bartlett E, Schomacker H, Surman S, Akira S, Bae YS, Collins P, Murphy B, Schmidt A.

J Virol. 2011 Feb;85(4):1495-506. doi: 10.1128/JVI.01297-10. Epub 2010 Dec 1.

47.
48.

Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.

Surman SL, Brown SA, Jones BG, Woodland DL, Hurwitz JL.

AIDS Res Hum Retroviruses. 2010 Jul;26(7):783-93. doi: 10.1089/aid.2009.0266.

49.

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Brown SA, Surman SL, Sealy R, Jones BG, Slobod KS, Branum K, Lockey TD, Howlett N, Freiden P, Flynn P, Hurwitz JL.

Viruses. 2010 Feb 1;2(2):435-467.

50.

Short communication: The dead cell: a potent escort for HIV type 1 transinfection.

Sealy R, Jones BG, Surman SL, Hurwitz JL.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1123-8. doi: 10.1089/aid.2009.0021.

Supplemental Content

Loading ...
Support Center